Adjunctive Rifampicin Increases Antibiotic Efficacy in Group A Streptococcal Tissue Infection Models
- 18 October 2021
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (11)
Abstract
Biofilm has recently been highlighted as a complicating feature of necrotizing soft tissue infections (NSTI) caused by Streptococcus pyogenes (i.e., group A Streptococcus [GAS]) contributing to a persistence of bacteria in tissue despite prolonged antibiotic therapy. Here, we assessed the standard treatment of benzylpenicillin and clindamycin with or without rifampin in a tissue-like setting.Keywords
Funding Information
- Center for Innovative Medicine and Region Stockholm (20180058)
- Swedish Research Council (2018-02475)
- Norges Forskningsråd (2018-151)
- Swedish Governmental agency for innovation Systems VINNOVA (90456)
- Swedish Research Council (2018-05620)
- Karolinska Institutet
This publication has 30 references indexed in Scilit:
- Increased cytotoxicity and streptolysin O activity in group G streptococcal strains causing invasive tissue infectionsScientific Reports, 2015
- Clinical Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Patients With Streptococcal Toxic Shock Syndrome: A Comparative Observational StudyClinical Infectious Diseases, 2014
- Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal InfectionsClinical Infectious Diseases, 2014
- Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitisMicrobial Pathogenesis, 2011
- Viable Group A Streptococci in Macrophages during Acute Soft Tissue InfectionPLOS Medicine, 2006
- Bacterial biofilms: from the Natural environment to infectious diseasesNature Reviews Microbiology, 2004
- Biofilm Formation by Group A Streptococci: Is There a Relationship with Treatment Failure?Journal of Clinical Microbiology, 2003
- Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shockCritical Care Medicine, 1996
- Treatment of Septic Shock with Human Monoclonal Antibody HA-1AAnnals of Internal Medicine, 1994
- The Eagle Effect Revisited: Efficacy of Clindamycin, Erythromycin, and Penicillin in the Treatment of Streptococcal MyositisThe Journal of Infectious Diseases, 1988